Industry News
Lightwaves used by neuroscientists to improve brain tumor surgery
Jan 31, 2014
First-of-its-kind research by the Innovation Institute at Henry Ford Hospital shows promise for developing a method of clearly identifying cancerous tissue during surgery on one of the most common and deadliest types of brain tumor. Read More
Repeat colonoscopy examined in patients with polyps referred for surgery without biopsy-proven cancer
Jan 31, 2014
A new study reports that in the absence of biopsy-proven invasive cancer, a second colonoscopy done at an expert center may be appropriate to reevaluate patients referred for surgical resection. In the study, 71 percent of the lesions referred for surgery were noncancerous polyps (growths in the colon) and were treatable endoscopically. Read More
Repeat colonoscopy examined in patients with polyps referred for surgery without biopsy-proven cancer
Jan 31, 2014
A new study reports that in the absence of biopsy-proven invasive cancer, a second colonoscopy done at an expert center may be appropriate to reevaluate patients referred for surgical resection. In the study, 71 percent of the lesions referred for surgery were noncancerous polyps (growths in the colon) and were treatable endoscopically. Read More
New study finds link between slow reaction time and early death
Jan 30, 2014
A new study, published in the journal PLOS ONE, has found that adults who have slow reaction times have a higher risk of an early death.Reaction time was studied because it reflects how well the central nervous system is working. It also reflects basic mental skills, such as how quickly a person is able to process information. Read More
Final results from the Phase 3 PREVAIL trial of enzalutamide
Jan 30, 2014
Medivation Inc. and Astellas Pharma Inc. have announced final results on the primary and secondary efficacy endpoints from the Phase 3 PREVAIL trial of enzalutamide in patients with chemotherapy-naïve metastatic prostate cancer who have failed androgen deprivation therapy and have few or no symptoms. Read More
Provectus announces PV-10's assessment for drug-drug interaction potential
Jan 30, 2014
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, and XenoTech, a preclinical CRO and pioneer in collaborative research surrounding in vitro drug metabolism and pharmacokinetics (DMPK) services, has announced that an article describing a study to determine the potential of rose bengal disodium to cause drug-drug interactions has been... Read More
Classification system for bladder cancer prognosis
Jan 30, 2014
Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development. Read More
Mouse model demonstrates role for metabolic enzyme in acute myeloid leukemia
Jan 30, 2014
In recent years, mutations in two metabolic enzymes, isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2), have been identified in approximately 20 percent of all acute myeloid leukemias (AML). As a result, mutant IDH proteins have been proposed as attractive drug targets for this common form of adult leukemia. Read More
In certain breast cancers, melatonin shows potential to slow tumor growth
Jan 30, 2014
An early stage study shows melatonin - a hormone that regulates the body's sleep and awake cycles - may have the potential to help slow the growth of certain breast cancer tumors, according to researchers from Henry Ford Hospital in Detroit and Foundation for Research Support of the State of São Paulo. Read More
Popularity of indoor tanning among younger people 'alarming'
Jan 30, 2014
New research analyzing the prevalence of indoor tanning has revealed the activity is very common in Western countries, particularly among young people. Because the use of tanning beds has been associated with a higher risk of skin cancers, researchers say its popularity is a public health risk.Indoor tanning exposes the user to ultraviolet (UV) radiation. Read More
Previous Page Next Page